Search results
Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock...
Benzinga via AOL· 6 days agoMonday, Addex Therapeutics (NASDAQ:ADXN) released top-line data from a Phase 2 epilepsy study...
Mum, 29, discovers deadly cause of 'hysterical attacks' after blaming break up
The US Sun· 2 weeks agoA MUM discovered she had epilepsy six years after doctors first thought she was having “hysterical”...
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study - Addex Therapeutics (NASDAQ:ADXN)
Benzinga· 7 days agoAd Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2024 - Addex Therapeutics (NASDAQ:ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule
The Therapeutic Evolution of THC: From Recreational Use to Pharmaceutical Ingredient
Rolling Stone· 2 weeks agoIn recent years, the perception of tetrahydrocannabinol (THC), the primary psychoactive compound in...
Akron woman experiences rare skin reaction after allergic reaction to medication
News Channel 5 Cleveland· 2 weeks agoInstead, she experienced a rare, severe reaction to a medication she'd just been prescribed. Kimberly Cannon feels thankful she went to the emergency room when she did, "my ...